Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Delgado

Showing results (231-240 of 289) with videos related to

Pageof 29
Sort By:
Cardiovascular Diabetology|December 8, 2025
Circulating long non-coding RNAs as predictors of type 2 diabetes mellitus development: results from the CORDIOPREV studyHatim Boughanem, María José Párraga-Viúdez, Ana Ojeda-Rodríguez, et al.
Cardiovascular Diabetology|August 3, 2023
Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV studyAlejandro Villasanta-Gonzalez, Marina Mora-Ortiz, Juan F Alcala-Diaz, et al.
Medicina Clinica|September 6, 2017
Quantitative evaluation of capillaroscopic microvascular changes in patients with established coronary heart diseaseM Esther Sanchez-Garcia, Irene Ramirez-Lara, Francisco Gomez-Delgado, et al.
Stroke|August 10, 2021
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled TrialJose Jimenez-Torres, Juan F Alcalá-Diaz, Jose D Torres-Peña, et al.
Clinical and Translational Medicine|May 1, 2021
A microbiota-based predictive model for type 2 diabetes remission induced by dietary intervention: From the CORDIOPREV studyCristina Vals-Delgado, Juan F Alcala-Diaz, Irene Roncero-Ramos, et al.
The Journal of Clinical Endocrinology and Metabolism|October 29, 2024
Decreased Neutrophils Are Associated With Reduced Risk of Type 2 Diabetes Incidence: Results From the CORDIOPREV StudyHatim Boughanem, Antonio Pablo Arenas de Larriva, Antonio Camargo, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2011
Interleukin 1B variant -1473G/C (rs1143623) influences triglyceride and interleukin 6 metabolismJavier Delgado-Lista, Antonio Garcia-Rios, Pablo Perez-Martinez, et al.
Molecular Nutrition & Food Research|December 8, 2011
Insulin receptor substrate-2 gene variants in subjects with metabolic syndrome: association with plasma monounsaturated and n-3 polyunsaturated fatty acid levels and insulin resistancePablo Perez-Martinez, Javier Delgado-Lista, Antonio Garcia-Rios, et al.
Nutrition & Diabetes|May 16, 2024
Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trialAlicia Podadera-Herreros, Antonio P Arenas-de Larriva, Francisco M Gutierrez-Mariscal, et al.
The American Journal of Clinical Nutrition|March 11, 2011
Calpain-10 interacts with plasma saturated fatty acid concentrations to influence insulin resistance in individuals with the metabolic syndromePablo Perez-Martinez, Javier Delgado-Lista, Antonio Garcia-Rios, et al.
Pageof 29

Showing results (231-240 of 289) with videos related to

Sort By:
Pageof 29
Cardiovascular Diabetology|December 8, 2025
Circulating long non-coding RNAs as predictors of type 2 diabetes mellitus development: results from the CORDIOPREV studyHatim Boughanem, María José Párraga-Viúdez, Ana Ojeda-Rodríguez, et al.
Cardiovascular Diabetology|August 3, 2023
Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV studyAlejandro Villasanta-Gonzalez, Marina Mora-Ortiz, Juan F Alcala-Diaz, et al.
Medicina Clinica|September 6, 2017
Quantitative evaluation of capillaroscopic microvascular changes in patients with established coronary heart diseaseM Esther Sanchez-Garcia, Irene Ramirez-Lara, Francisco Gomez-Delgado, et al.
Stroke|August 10, 2021
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled TrialJose Jimenez-Torres, Juan F Alcalá-Diaz, Jose D Torres-Peña, et al.
Clinical and Translational Medicine|May 1, 2021
A microbiota-based predictive model for type 2 diabetes remission induced by dietary intervention: From the CORDIOPREV studyCristina Vals-Delgado, Juan F Alcala-Diaz, Irene Roncero-Ramos, et al.
The Journal of Clinical Endocrinology and Metabolism|October 29, 2024
Decreased Neutrophils Are Associated With Reduced Risk of Type 2 Diabetes Incidence: Results From the CORDIOPREV StudyHatim Boughanem, Antonio Pablo Arenas de Larriva, Antonio Camargo, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2011
Interleukin 1B variant -1473G/C (rs1143623) influences triglyceride and interleukin 6 metabolismJavier Delgado-Lista, Antonio Garcia-Rios, Pablo Perez-Martinez, et al.
Molecular Nutrition & Food Research|December 8, 2011
Insulin receptor substrate-2 gene variants in subjects with metabolic syndrome: association with plasma monounsaturated and n-3 polyunsaturated fatty acid levels and insulin resistancePablo Perez-Martinez, Javier Delgado-Lista, Antonio Garcia-Rios, et al.
Nutrition & Diabetes|May 16, 2024
Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trialAlicia Podadera-Herreros, Antonio P Arenas-de Larriva, Francisco M Gutierrez-Mariscal, et al.
The American Journal of Clinical Nutrition|March 11, 2011
Calpain-10 interacts with plasma saturated fatty acid concentrations to influence insulin resistance in individuals with the metabolic syndromePablo Perez-Martinez, Javier Delgado-Lista, Antonio Garcia-Rios, et al.
Pageof 29